Found 54 matching trials
To Test Bioequivalence Between Two Tablet Formulations in the Treatment of Allergy PHASE1 This study is designed to assess bioequivalence between two products used f...
Show More Location
Algorithme Pharma Inc.
Learn More & Join Trial
Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions NA An open label, randomized, single-center, single-dose, two-treatment, two-p...
Show More Location
Bioanalytical Systems, Inc
Learn More & Join Trial
Comparing Standard-Dose and High-Dose Cetirizine for Acute Urticaria NA The goal of this clinical trial is to learn whether a higher dose of cetiri...
Show More Location
University of Phayao Hospital
Learn More & Join Trial
A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1) PHASE2 The study is a Phase II, dose-ranging, multicenter, randomized, double-blin...
Show More Location
Multiple Locations
Learn More & Join Trial
To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions PHASE1 To demonstrate the relative bioavailability of Cetirizine Hydrochloride/Pse...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase 1 Study of Levocetirizine PHASE1 This is a single center, single blind, single dose, randomized, partial cro...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis PHASE2 This study will assess the efficacy and safety of different doses of ACT-12...
Show More Location
Clinical Investigative Site 7905
Learn More & Join Trial
A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Non-fasting Conditions PHASE1 To determine the pharmacokinetics and bioequivalence of cetirizine hydrochl...
Show More Location
AAIPharma Inc.- AAI Clinic
Learn More & Join Trial
Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed) PHASE4 The primary objective of this study was to determine whether children ages ...
Show More Location
Multiple Locations
Learn More & Join Trial
Prevalence of Antihistamine Responsive Irritable Bowel Syndrome With Diarrhea N/A Irritable bowel syndrome is a functional disorder of the gastrointestinal t...
Show More Location
Multiple Locations
Learn More & Join Trial